Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-30

Clinical Trial Update: Characterization of New Phenotypes of Patients With Spinal Muscular Atrophy Treated With SMN Restoring Therapy [NA]

View source ↗

Summary

This clinical trial investigates new phenotypes among Spinal Muscular Atrophy patients treated with SMN-restoring therapy. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SMN Restoring Therapy

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Spinal Muscular Atrophy | NA | Status: RECRUITING